Skip to main content
SpringerLink
Log in

GM2 Gangliosidosis

  • Chapter
Magnetic Resonance of Myelination and Myelin Disorders

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 509.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 649.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Further Reading

  • Argov Z, Navon R. Clinical and genetic variations in the syndrome of adult GM2 gangliosidosis resulting from hexosaminidase A deficiency. Ann Neurol 1984; 16: 14–20

    Article  CAS  PubMed  Google Scholar 

  • Bach G, Tomczak J, Risch N, Ekstein J. Tay-Sachs screening in the Jewish Ashkenazi population: DNA testing is the preferred procedure. Am J Med Genet 2001; 99: 70–75

    Article  CAS  PubMed  Google Scholar 

  • Barnes D, Misra VP, Young EP, Thomas PK, Harding AE. An adult onset hexosaminidase A deficiency syndrome with sensory neuropathy and internuclear ophthalmoplegia. J Neurol Neurosurg Psychiatry 1991; 54: 1112–1113

    CAS  PubMed  Google Scholar 

  • Barness LA, Henry K, Kling P, Laxova R, Kaback M, Gilbert-Barness E. A 7-year old white-male boy with progressive neurological deterioration. Am J Med Genet 1991; 40: 271–279

    Article  CAS  PubMed  Google Scholar 

  • Beck M, Sieber N, Goebel HH. Progressive cerebellar ataxia in juvenile GM2-gangliosidosis type Sandhoff. Eur J Pediatr 1998; 157: 866–867

    Article  CAS  PubMed  Google Scholar 

  • Brett EM, Ellis RB, Haas L, Ikonne JU, Lake BD, Patrick AD, Stephens R. Late onset GM2 gangliosidosis: clinical, pathological, and biochemical studies on 8 patients. Arch Dis Child 1973; 48: 775–785

    CAS  PubMed  Google Scholar 

  • Brismar J, Brismar G, Coates R, Gascon G, Ozand P. Increased density of the thalamus on CT scans in patients with GM2 gangliosidosis. Am J Neurol 1990; 11: 125–130

    CAS  Google Scholar 

  • Çaliskan M, Özmen M, Beck M, Apak S. Thalamic hyperdensity — is it a diagnostic marker for Sandhoff disease? Brain Dev 1993; 15: 387–388

    Article  PubMed  Google Scholar 

  • Chavany C, Jendoubi M. Biology and potential strategies for the treatment of GM2 gangliosidosis. Mol Med Today 1998; 4: 158–165

    CAS  PubMed  Google Scholar 

  • Chen B, Rigat B, Curry C, Mahuran DJ. Structure of the GM2A gene: identification of an exon 2 nonsense mutation and a naturally occurring transcript with an in-frame deletion. Am J Hum Genet 1999; 65: 77–87

    CAS  PubMed  Google Scholar 

  • Conzelmann E, Kytzia HJ, Navon R, Sandhoff K. Ganglioside GM2N-acetyl-β-D-galactosaminidase activity in cultured fibroblasts of late-infantile and adult GM2 gangliosidosis patients and of healthy probands with low hexosaminidase level. Am J Hum Genet 1983; 35: 900–913

    CAS  PubMed  Google Scholar 

  • Cordeiro P, Hechtman P, Kaplan F. The GM2 gangliosidoses data-bases: allelic variation at the HEXA, HEXB, and GM2A. Genet Med 2000; 2: 319–327

    CAS  PubMed  Google Scholar 

  • Di Gregorio F, Ferrari G, Marini P, Siliprandi R, Gorio A. The influence of gangiosidosis on neurite growth regeneration. Neuropediatrics 1984; 15: 93–96

    PubMed  Google Scholar 

  • D’Souza G, McCann CL, Hedrick J, Fairley C, Nagel HL, Kushner JD, Kessel R. Tay-Sachs disease carrier screening: a 21-year experience. Genet Test 2000; 4: 257–263

    CAS  PubMed  Google Scholar 

  • Federico A, Palmeri S, Malandrini A, Fabrizi G, Mondelli M, Guazzi GC. The clinical aspects of adult hexosaminidase deficiencies. Dev Neurosci 1991; 13: 280–287

    CAS  PubMed  Google Scholar 

  • Fukumizu M, Yoshikawa H, Takashima N, Kurokawa T. Tay-Sachs disease: progression of changes on neuroimaging in four cases. Neuroradiology 1992; 34: 483–486

    Article  CAS  PubMed  Google Scholar 

  • Goebel HH, Stolte G, Kustermann-Kuhn B, Harzer K. B1 Variant of GM2 gangliosidosis in a 12-year-old patient. Pediatr Res 1989; 25: 89–93

    CAS  PubMed  Google Scholar 

  • Gordon BA, Gordon KE, Hinton GG, Cadera W, Feleki V, Bayleran J, Hechtman P. Tay-Sachs disease: B1 variant. Pediatr Neurol 1988; 4: 54–57

    Article  CAS  PubMed  Google Scholar 

  • Gray RGF, Green A, Rabb L, Broadhead DM, Besley GTN. A case of the B1 variant of GM2-gangiosidosis. J Inherit Metab Dis 1990; 13: 280–282

    CAS  PubMed  Google Scholar 

  • Grosso S, Farnetani MA, Berardi R, Margollicci M, Galluzzi P, Vivarelli R, Morgese G, Balestri P. GM2 gangliosidosis variant B1. Neuroradiologic features. J Neurol 2003; 250: 17–21

    Article  PubMed  Google Scholar 

  • Guidotti JE, Mignon A, Haase G, Caillaud C, McDonnell N, Kahn A, Poenaru L. Adenoviral gene therapy of the Tay-Sachs disease in hexosaminedase A-deficient knock-out mice. Hum Mol Genet 1999; 8: 831–838

    Article  CAS  PubMed  Google Scholar 

  • Hittmair K, Wimberger D, Bernert G, Mallek R, Schindler EG. MRI in a case of Sandhoff’s disease. Neuroradiology 1996; 38: S178–S180

    PubMed  Google Scholar 

  • Hund E, Grau A, Fogel W, Fosting M, Cantz M, Kunstermann-Kuhn B, Harzer K, Navon R, Goebel HH, Meinck H-M. Progressive cerebellar ataxia, proximal neurogenic weakness and ocular motor disturbances: hexosaminidase A deficiency with late onset in four siblings. J Neurol Sci 1997; 145:25–31

    Article  CAS  PubMed  Google Scholar 

  • Jeyakumar M, Butters TD, Cortina-Borja M, Hunnam V, Proia RL, Pery VH, Dwek RA, Platt FM. Delayed symptom onset and increased life expectancy in Sandhoff disease mice treated with N-butyldeoxynojirimycin. Proc Natl Acad Sci 1999; 96: 6388–6393

    Article  CAS  PubMed  Google Scholar 

  • Jeyakumar M, Norflus F, Tifft CJ, Cortina-Borja M, Butters TD, Proia RL, Perry VH, Dwek RA, Platt FM. Enhanced survival in Sandhoff disease mice receiving a combination of substrate deprivation therapy and bone marrow transplantation. Blood 2001; 97: 327–329

    Article  CAS  PubMed  Google Scholar 

  • Johnson WG, Chutorian A, Miranda A. A new juvenile hexosaminidase deficiency disease presenting as cerebellar ataxia: clinical and biochemical studies. Neurology 1977; 27: 1012–1018

    CAS  PubMed  Google Scholar 

  • Karni A, Navon R, Sadeh M. Hexosaminidase A deficiency manifesting as spinal muscular atrophy of late onset. Ann Neurol 1988; 24: 451–453

    Article  CAS  PubMed  Google Scholar 

  • Koelfen W, Freund M, Jaschke W, Koenig S, Schultze C. GM2 gangliosidosis (Sandhoff’s disease): two year follow-up by MRI. Neuroradiology 1994; 36: 152–154

    Article  CAS  PubMed  Google Scholar 

  • Kotagal S, Wenger DA, Alcala H, Gomez C, Horenstein S. AB variant GM2 gangliosidosis: cerebrospinal fluid and neuropathologic characteristics. Neurology 1986; 36: 438–440

    CAS  PubMed  Google Scholar 

  • Kroll RA, Pagel MA, Roman-Goldstein S, Barkovich AJ, D’Agostino AN, Neuwelt EA. White matter changes associated with Feline GM2 gangliosidosis (Sandhoff disease): correlation of MR findings with pathologic and ultrastructural abnormalities. AJNR Am J Neuroradiol 1995; 16: 1912–1226

    Google Scholar 

  • Lui Y, Wada R, Kawai H, Sango K, Deng C, Tai T, McDonald MP, Araujo K, Crawley JN, Bierfreund U, Sandhoff K, Suzuki K, Prioa RL. A genetic model of substrate deprivation therapy for a glycosphingolipid storage disorder. J Clin Invest 1999; 103: 497–505

    Google Scholar 

  • Meek D, Wolfe LS, Andermann E, Andermann F. Juvenile progressive dystonia: a new phenotype of GM2 gangliosidosis. Ann Neurol 1984; 15: 348–352

    Article  CAS  PubMed  Google Scholar 

  • Mugikura S, Takahashi S, Higano S, Kurihara N, Kon K, Sakamoto K. MR findings in Tay-Sachs disease. J Comput Assist Tomogr 1996; 20: 551–555

    Article  CAS  PubMed  Google Scholar 

  • Nassogne MC, Commare MC, Lellouch-Tubiana A, Emond S, Zerah M, Caillaud C, Hertz-Pannier L, Saudubray JM. Unusual presentation of GM2 gangliosidosis mimicking a brain stem tumor in a 3-year-old girl. AJNR Am J Neuroradiol 2003; 24: 840–842

    PubMed  Google Scholar 

  • Navon R. Molecular and clinical heterogeneity of adult GM2 gangliosidosis. Dev Neurosci 1991; 13: 295–298

    CAS  PubMed  Google Scholar 

  • Navon R, Argov Z, Brand N, Sandbank U. Adult GM2 gangliosidosis in association with Tay-Sachs disease: a new phenotype. Neurology 1981; 31: 1397–1401

    CAS  PubMed  Google Scholar 

  • Navon R, Argov Z, Frisch A. Hexosaminidase A deficiency in adults. Am J Med Genet 1986; 24: 179–196

    Article  CAS  PubMed  Google Scholar 

  • Neote K, Mahuran DJ, Gravel RA. Molecular genetics of β-hexosaminidase deficiencies. Adv Neurol 1991; 56: 189–207

    CAS  PubMed  Google Scholar 

  • Neufeld EF. Natural history and inherited disorders of a lysosomal enzyme α-hexosaminidase. J Biol Chem 1989; 264: 10927–10930

    CAS  PubMed  Google Scholar 

  • Norflus F, Tifft CJ, McDonald MP, Goldstein G, Crawley JN, Hoffmann A, Sandhoff K, Suzuki K, Proia RL. Bone marrow transplantation prolongs life span and ameliorates neurologic manifestations in Sandhoff disease mice. J Clin Invest 1998; 101: 1881–1888

    CAS  PubMed  Google Scholar 

  • Oya Y, Proia RL, Norflus F, Tifft CJ, Langaman C, Suzuki K. Distribution of enzyme-bearing cells in GM2 gangliosidosis mice: regionally specific pattern of cellular infiltration following bone marrow transplantation. Acta Neuropathol (Berl) 2000; 99: 161–168

    Article  CAS  PubMed  Google Scholar 

  • Paw BH, Moskowitz SM, Uhrhammer N, Wright N, Kaback MM, Neufeld EF. Juvenile GM2 gangliosidosis caused by substitution of histidine for arginine at position 499 or 504 of the α-subunit of β-hexosaminidase. J Biol Chem 1990; 265: 9452–9457

    CAS  PubMed  Google Scholar 

  • Platt FM, Butters TD. New therapeutic prospects for the glycosphingolipid lysosomal storage diseases. Biochem Pharmacol 1998; 56: 421–430

    CAS  PubMed  Google Scholar 

  • Platt FM, Neises GR, Reinkensmeier G, Towsend MJ, Perry VH, Proia RL, Winchester B, Dwek RA, Buters TD. Prevention of lysosomal storage in Tay-Sachs mice treated with N-butyldeoxynojirimycin. Science 1997; 276: 428–431

    Article  CAS  PubMed  Google Scholar 

  • Platt FM, Jeyakumar M, Andersson U, Priestman DA, Dewk RA, Butters TD. Inhibition of substrate synthesis as a strategy for glycolipid lysosomal storage disease therapy. J Inherit Metab Dis 2001; 24: 275–290

    Article  CAS  PubMed  Google Scholar 

  • Pullarkat RK, Reha H, Beratis NG. Accumulation of ganglioside GM2 in cerebrospinal fluid of a patient with the variant AB of infantile GM2 gangliosidosis. Pediatrics 1981; 68:106–108

    CAS  PubMed  Google Scholar 

  • Rapin I, Suzuki K, Suzuki K, Valsamis MP. Adult (chronic) GM2 gangliosidosis: atypical spinocerebellar degeneration in a Jewish sibship. Arch Neurol 1976; 33: 120–130

    CAS  PubMed  Google Scholar 

  • Rattazzi MC, Dobrenis K. Treatment of GM2 gangliosidosis: past experiences, implications, and future prospects. Adv Genet 2001; 44: 317–339

    CAS  PubMed  Google Scholar 

  • Rubin M, Karpati G, Wolfe LS, Carpenter S, Klavins MH, Mahuran DJ. Adult onset motor neuropathy in the juvenile type of hexosaminidase A and B deficiency. J Neurol Sci 1988; 87: 103–119

    Article  CAS  PubMed  Google Scholar 

  • Salaman MS, Clarcke JTR, Midroni G, Waxman MB. Peripheral and autonomic nervous system involvement in chronic GM2-gangliocidosis. J Inherit Metab Dis 2001; 24: 65–71

    Google Scholar 

  • Sandhoff K, Harzer K, Wässle W, Jatzkewitz H. Enzyme alterations and lipid storage in three variants of Tay-Sachs disease. J Neurochem 1971; 8: 2469–2489

    Google Scholar 

  • Schepers U, Glombitza G, Lemm T, Hoffmann A, Chabas A, Ozand P, Sandhoff K. Molecular analysis of a GM2-activator deficiency in two patients with GM2-gangliosidosis AB variant. Am J Hum Genet 1996; 59: 1048–105

    CAS  PubMed  Google Scholar 

  • Schnorf H, Gitzelmann R, Bosshard NU, Spycher M, Waespe W. Early and severe sensory loss in three adult siblings with hexosaminidase A and B deficiency (Sandhoff disease). J Neurol Neurosurg Psychiatry 1995; 59: 520–523

    CAS  PubMed  Google Scholar 

  • Specola N, Vanier MT, Goutières F, Mikol J, Aicardi J. The juvenile and chronic forms of GM2 gangliosidosis: clinical and enzymatic heterogeneity. Neurology 1990; 40: 145–150

    CAS  PubMed  Google Scholar 

  • Streifler JY, Gornish M, Hadar H, Gadoth N. Brain imaging in late-onset GM2 gangliosidosis. Neurology 1993; 43: 2055–2058

    CAS  PubMed  Google Scholar 

  • Suzuki K, Vanier MT. Biochemical and molecular aspects of late-onset GM-2 gangiosidosis: B1 variant as a phenotype. Dev Neurosci 1991; 13: 288–294

    CAS  PubMed  Google Scholar 

  • Thomas PK, Young E, King RHM. Sandhoff disease mimicking adult-onset bulbospinal neuropathy. J Neurol Neurosurg Psychiatry 1989; 52: 1103–1106

    CAS  PubMed  Google Scholar 

  • Wada R, Tifft CJ, Proia RL. Microglial activation precedes acute neurodegenration in Sandhoff disease and is suppressed by bone marrow transplantation. Proc Nat Acad Sci 2000; 97:10954–10959

    CAS  PubMed  Google Scholar 

  • Walkley SU, Siegel DA, Dobrenis K. GM2 Gangliosidosis and pyramidal neuron dendritogenesis. Neurochem Res 1995; 20: 1287–1299

    Article  CAS  PubMed  Google Scholar 

  • Walkley SU, Siegel DA, Dobrenis K, Zervas M. GM2 gangliosidosis as a regulator of pyramidal neuron dendritogenesis. Ann NY Acad Sci 1998; 845: 188–199

    CAS  PubMed  Google Scholar 

  • Walkley SU, Zervas M, Wiseman S. Gangliosidosis as modulators of dendritogenesis in normal and storage disease-affected pyramidal neurons. Cereb Cortex 2000; 10: 1028–1037

    Article  CAS  PubMed  Google Scholar 

  • Ward CP, Fensom AH, Green PM. Biallelic discrimination assays for the three common Ashkenazi Jewish mutations and a common non-Jewish mutation, in Tay-Sachs disease, using fluorogenic taqman probes. Genet Test 2000; 4: 351–358

    Article  CAS  PubMed  Google Scholar 

  • Willner JP, Grabowski GA, Gordon RE, Bender AN, Desnick RJ. Chronic GM2 gangliosidosis masquerading as atypical Friedreich ataxia: clinical, morphologic, and biochemical studies of nine cases. Neurology 1981; 31: 787–798

    CAS  PubMed  Google Scholar 

  • Yoshikawa H, Yamada K, Sakuragawa N. MRI in the early stage of Tay-Sachs disease. Neuroradiology 1992; 34: 394–395

    Article  CAS  PubMed  Google Scholar 

  • Yüksel A, Yalçinkaya C, I0lak C, Gündüz E, Seven M. Neuroimaging findings in four patients with Sandhoff disease. Pediatr Neurol 1999; 21: 562–565

    Article  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

(2005). GM2 Gangliosidosis. In: Magnetic Resonance of Myelination and Myelin Disorders. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27660-2_10

Download citation

  • DOI: https://doi.org/10.1007/3-540-27660-2_10

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-22286-6

  • Online ISBN: 978-3-540-27660-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation